Published Date: May 2025 | Report ID: MI2829 | 218 Pages
The Europe Pet Diseases Treatment market accounted for USD 4.02 Billion in 2024 and USD 4.32 Billion in 2025 is expected to reach USD 8.92 Billion by 2035, growing at a CAGR of around 7.52% between 2025 and 2035. The European pet diseases treatment market is driven by rising chronic illnesses in aging pets, growing pet humanization, and expanding veterinary telemedicine services. In Europe, the Pet Diseases Treatment Market concentrates on the identification, care, and management of diseases affecting pets like dogs, cats, and small mammals. More and more people care about their pets’ health, develop strong bonds with them, and demand better veterinary services. Usually, people use pharmaceuticals, vaccines, and surgeries directed at certain diseases, along with dietary supplements. Thanks to new technologies, healthcare professionals can now find and treat diseases sooner. Checking up on health frequently and getting vaccinations is being recognized as important.
There is more support for the market with the increase in veterinary clinics and pet insurance available in Europe. Veterinary professionals are now using digital tools so that they can more easily provide care in areas where it is not so easy to visit in person. Many pet owners are now choosing personalized medicines and holistic care for their pets with chronic health conditions. With regular progress in both pet care and treatment methods, the market is always evolving.
"In Europe, pet diseases such as chronic conditions, infectious diseases, and genetic disorders are increasingly recognized as major health concerns. The rise in aging pet populations has led to more cases of arthritis, diabetes, and cancer, requiring advanced diagnostic and treatment approaches. Furthermore, emerging infectious diseases and parasitic infections remain challenges, especially with climate change affecting vector distribution. Preventive care and early detection are critical to managing these diseases effectively. Veterinary research across Europe continues to focus on improving treatment protocols and promoting pet health awareness to reduce disease burden."
| Parameter | Details |
|---|---|
| Largest Market | Europe |
| Fastest Growing Market | Europe |
| Base Year | 2024 |
| Market Size in 2024 | USD 4.02 Billion |
| CAGR (2025-2035) | 7.52% |
| Forecast Years | 2025-2035 |
| Historical Data | 2018-2024 |
| Market Size in 2035 | USD 8.92 Billion |
| Countries Covered | Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Belgium, Sweden, Poland, Portugal, Greece, Czech Republic, Hungary, Finland, and Others |
| What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies |
| Segments Covered | Disease Type, Treatment Type, Pet Type, End-user, and Country |
To explore in-depth analysis in this report - Request Sample Report
Rising numbers of chronic conditions in pets, such as diabetes, arthritis, and allergies, are strongly influencing the European Pet Diseases Treatment Market. Since pets are healthier and eat better, conditions related to age are becoming more frequent and must be managed regularly. Pets with chronic diseases regularly need veterinary care, ongoing medicines, and help with diagnostics, leading to a higher need for veterinary care.
As arthritis affects aging dogs, they may be put on regular pain medications and joint supplements, and animals with diabetes must be treated with insulin and their health constantly monitored. As a result, pets are protected more, and pet owners choose to use advanced veterinary treatments. FEDIAF explains that the aging of pets is leading to more families in Europe focusing on treating and controlling chronic pet conditions. Long-term treatment solutions are now more important due to this trend, which is supporting the development of chronic illness care in the regional market.
People increasingly treat their pets like part of the family, which has made the European Pet Diseases Treatment Market grow. Due to this shift, many people now expect their pets to receive medical care that matches medical care for humans. More and more, pet owners are turning to veterinarians for advanced diagnostics, preventive health care, and unique treatment for their pets.
Many more pets are getting and using premium products that meet their particular health needs. The organization FEDIAF explains that 91 million European households (approximately half of them) own one of Europe’s 340 million pets, a clear sign of the closeness people now have with their pets. The increasing tendency to care for animals is a major reason for growth in Europe’s pet healthcare industry.
A key challenge in the European Pet Diseases Treatment Market is that advanced treatments are very expensive, so many households can’t afford them. Diagnosing, operating, and treating chronic illness in animals can be costly for pet owners. This becomes much harder in regions that do not have a strong pet insurance system.
Certain areas with access to specialists can enjoy specialist services, while others depend on typical or delayed care, which affects the market’s growth and outreach. Much of the treatments for cancer, disorders of the endocrine system, and problems related to bones and joints are costly, and so they’re beyond the reach of many families. Being unequal economically means a lot of pets do not get the latest animal health services because few can afford them.
Creating individualized care for animals and treatment plans is bringing many opportunities to the European Pet Diseases Treatment Market. Because veterinary medicine is developing, there is greater attention given to tailoring treatment for specific pets based on breed, genetics, age, and health. Basically, it results in more effective care that causes fewer side effects and improves outcomes, mainly for long-term diseases like cancer, disorders related to the endocrine system, and allergies.
People who own pets are moving toward investing in more accurate detection, genetics, and drugs targeted to their needs. People are now expecting their pets to have personalized care as pet owners humanize them more. Further, European veterinary clinics and drug makers are starting to apply digital tools to provide individualized care for animals. As people know more about personalized care, it is likely to change the market’s focus, offering more chances for innovation and top service.
Using alternative and natural therapies to treat chronic and behavioral illnesses in animals is becoming a major area of growth in the European Pet Diseases Treatment Market. More and more pet owners are turning to natural methods to manage issues like arthritis, anxiety, problems with the skin, and upset stomach. Their safety and few side effects have made herbal remedies, acupuncture, aromatherapy, and homeopathy more popular than ever.
More owners are seeking mild, gentle therapy for their aging pets as they learn about how long-term drug treatments can harm them. In Germany and France, whose wellness culture is strong, veterinarians are moving towards using more alternative treatments. Also, as more pet wellness products are made and more specialist clinics are available, this trend is encouraged. Increasing consumer interest in natural products allows companies to introduce innovation and grow the pet healthcare sector.
Based on the product type, the European Pet Diseases Treatment Market has been classified into Infectious Diseases, Genetic Disorders, and Non-Infectious Diseases. Non-Infectious Diseases make up the largest and most important segment in the European Pet Diseases Treatment Market. Because arthritis, diabetes, heart problems, and cancer affect a large number of older pets, the pet pharmaceutical sector has become dominant. More pet owners are starting to look for ways to monitor their pets’ conditions over a long period, such as using specific drugs, planning the right diet, and following up with regular visits to the vet.
Would you like to review the price list for each section?
There has been an increase in allergies and skin problems, so many are asking for advanced methods of diagnosis and treatment. Because people view pets as family, priorities in pet healthcare now include paying more attention to quality of life and prevention. We also see vets across Europe getting new diagnostic tools and developing unique treatment programs for common non-infectious diseases. Another reason pet insurance is becoming more popular is that dealing with these diseases is very costly. As more is learned about this segment, it is still at the heart of new strategies and added services in the region.
Based on the product type, the Europe Pet Diseases Treatment Market has been classified into Medication, Surgical Interventions, Preventive Care, and Alternative Therapies. Medication forms the largest and most dominant category of treatments in the European Pet Diseases Treatment Market. Both prescription and over-the-counter drugs are used to treat infections, chronic illnesses, pain, and problems related to inflammation. The increase in pets developing arthritis, diabetes, and various allergies has made pharmaceutical drugs a regular demand in veterinary medicine.
More and more European pet owners choose vet-recommended drugs to control symptoms and help with diseases, but for lighter problems and preventative healthcare, over-the-counter medications are preferred. Advancements in pet medicine, such as tablets you can flavor for pets and liquid treatments for the skin, support compliance and accessibility. In addition, having solid regulations protects the quality of veterinary drugs, which encourages more people to rely on them. The availability of well-established veterinary pharmacy systems in the area helps people get these treatments quickly.
Large numbers of pets and well-equipped veterinary facilities have placed Germany at the top of Europe’s pet disease treatment market. Germany’s pet owners often choose preventive options, which leads to a need for vaccines, diagnostic tools, and supplements. The veterinary practice is carefully regulated, and Canada is home to both businesses and research centers involved in veterinary drugs. A larger number of people getting interested in natural and homeopathic solutions is shaping the market. Programs that increase public knowledge and efforts by veterinary associations assist in identifying and managing diseases in pets soon after they appear. In cities, more people are using advanced care for pets than in rural locations.
The growth of France’s pet disease treatment market is supported by the rise in pets and the strong importance placed on animal welfare. The country has many veterinary clinics that give both traditional and holistic treatment. Most people in this country use preventive care, having regular checkups and being vaccinated. Animal health is supported by the government, which encourages responsible pet ownership. Chronic health management of pets is being simplified for French pet owners, thanks to teleconsultation options. More pet owners are now turning to dermatology and dental care for their pets.
The U.K. pet diseases treatment market is well-developed, relying on major veterinarian chains and independent practices. Many people in the U.K. are now choosing to protect their animals with insurance and advanced care for illnesses that age causes. Using technology for medical care has increased both access and convenience in veterinary care. Regular oversight helps maintain the quality of all pet health solutions. More attention is being given to mental health and therapy for pets in the U.K. Awareness events and planned pet health days encourage pets to see the vet for check-ups and disease prevention.
Rising awareness of pet health and more companion animals are fueling Italy’s pet disease treatment market. As people live in cities and adopt new ways of living, more families consider their pets to be family, which raises the need for high-quality pet medical care. Both public and private veterinary providers are increasing their focus on prevention. Some Italians are buying organic and specialty products for their pets. Basic veterinary services are enough for those living in rural regions, but cities are now quickly adopting sophisticated techniques. There is an increasing drive to inform pet owners about how to prevent disease and spot it early.
The European Pet Diseases Treatment Market is dominated by established regional firms that sell a variety of veterinary medications, vaccines, and preventive products. Virbac, Dechra Pharmaceuticals, Ceva Santé Animale, and Vetoquinol lead the industry by using their strong distribution systems and advanced research efforts. Such companies work hard on creating cutting-edge solutions for patients with chronic diseases, skin problems, and infections with parasites. Generics and strategies made for local markets are helping Chanelle Pharma, Livisto Group, and Le Vet Pharma increase their popularity.
More and more companies are extending their lines of products with natural and alternative therapies to keep up with what people want today. Many pet care businesses now work closely with veterinarians and operate digital systems for pet needs. Compliance with regulations and good product quality are the main ways players in this market stand out. More pet owners getting insurance and requiring costly treatments is making competition among the companies even stronger.
Europe Pet Diseases Treatment Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Sample Report
By Disease Type
By Treatment Type
By Pet Type
By End-user
ByRegion
Europe
List of Companies:
The Europe Pet Diseases Treatment market accounted for USD 4.02 Billion in 2024 and USD 4.32 Billion in 2025 is expected to reach USD 8.92 Billion by 2035, growing at a CAGR of around 7.52% between 2025 and 2035.
Development of personalized pet medicine and tailored treatment plans, growth of natural and alternative therapies for chronic and behavioral issues, and expansion of mobile veterinary services in underserved regions.
The largest segment is Medication, driven by widespread use in treating pet diseases. The fastest-growing segment is Preventive Care, boosted by rising awareness of vaccinations and health checks.
Germany will make a notable contribution to the European Pet Diseases Treatment Market due to its strong veterinary infrastructure and pet care awareness.
Leading players include Virbac, Dechra, Ceva Santé Animale, Vetoquinol, Chanelle Pharma, Livisto, Le Vet Pharma, and KRKA.
The Middle East & Africa Pet Diseases Treatment market accounted for USD 1.42 Billion in 2024 and USD 1.52 Billion in 2025 is expected to reach USD 3.06 Billion by 2035, growing at a CAGR of around 7.23% between 2025 and 2035.
The Latin America Pet Diseases Treatment market accounted for USD 2.01 billion in 2024 and USD 2.16 billion in 2025 is expected to reach USD 4.36 Billion by 2035, growing at a CAGR of around 7.30% between 2025 and 2035.
The North America Pet Diseases Treatment market accounted for USD 4.50 Billion in 2024 and USD 4.85 Billion in 2025 is expected to reach USD 10.2 Billion by 2035, growing at a CAGR of around 7.7% between 2025 and 2035.
The Asia Pacific Pet Disease Treatment Market accounted for USD 2.96 Billion in 2024 and USD 3.20 Billion in 2025 is expected to reach USD 7.05 Billion by 2035, growing at a CAGR of around 7.5% between 2025 and 2035.
Pet Diseases Treatment Market sector recorded a valuation of USD 11.85 Billion in 2024 and is poised to expand significantly, hitting USD 26.5 Billion by 2035, driven by a CAGR of 7.60% between 2024 and 2035.
Our analysts are ready to help you immediately.
We have received your request for Europe Pet Diseases Treatment Market research report. We value your interest in our services and are pleased to inform you that our dedicated research specialist will be reaching out to you shortly. If you have any further questions or require additional assistance, feel free to let us know via-